Cargando…
Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patients
Metformin has garnered more interest as a chemo-preventive agent given the increased liver cancer risk in diabetic patients. This work was undertaken to better understand the effect of metformin use on liver cancer risk in diabetic patients. A comprehensive literature search was performed in PubMed,...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428628/ https://www.ncbi.nlm.nih.gov/pubmed/28489794 http://dx.doi.org/10.1097/MD.0000000000006888 |